Curcumin, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases fibronectin expression

Fertility and Sterility

Volumn 91, Issue 5 SUPPL., 2009, Pages 2177-2184

  Malik, Minnie ^a   Mendoza, Mirian ^a   Payson, Mark ^a,b   Catherino, William H ^a,b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

apoptosis; curcumin; fibronectin; Leiomyoma; MAP kinase; myometrium; NF B

Indexed keywords

CASPASE 3; CASPASE 9; CURCUMIN; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; DRUG MECHANISM; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; LEIOMYOMA; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE CULTURE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL DIVISION; CURCUMIN; DIETARY SUPPLEMENTS; EXTRACELLULAR MATRIX; FEMALE; FIBRONECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEIOMYOMA; MYOMETRIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 65049088214     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.03.045     Document Type: Article

References (74)

1. Olufowobi O., Sharif K., Papaionnou S., Neelakantan D., Mohammed H., and Afnan M. Are the anticipated benefits of myomectomy achieved in women of reproductive age? A 5-year review of the results at a UK tertiary hospital. J Obstet Gynecol 24 (2004) 434-440
2. Salvig J.D., Petersen K.R., and Moller B.R. Acute abdominal pain caused by torsion of an enlarged non-pregnant uterus. J Obstet Gynaecol 25 (2005) 81-82
3. Sheiner E., Bashiri A., Levy A., Hershkovitz R., Katz M., and Mazor M. Obstetric characteristics and perinatal outcome of pregnancies with uterine leiomyomas. J Reprod Med 49 (2004) 182-186
4. Phelan J.P. Myomas and pregnancy. Obstet Gynecol Clin North Am 22 (1995) 801-805
5. Bulletti C., De Ziegler D., Levi Setti P., Cicinelli E., Polli V., and Stefanetti M. Myomas, pregnancy outcome, and in vitro fertilization. Ann NY Acad Sci 1034 (2004) 84-92
6. Szamatowicz J., Laudanski T., Bulkszas B., and Akerlund M. Fibromyomas and uterine contractions. Acta Obstet Gynecol Scand 76 (1997) 973-976
7. Salvador E., Bienstock J., Blakemore K.J., and Pressman E. Leiomyomata uteri, genetic amniocentesis, and the risk of second-trimester spontaneous abortion. Am J Obstet Gynecol 186 (2002) 913-915
8. Benson C.B., Chow J.S., Chang-Lee W., Hill J.A., and Doubilet P.M. Outcome of pregnancies in women with uterine leiomyomas identified by sonography in the first trimester. J Clin Ultrasound 29 (2001) 261-264
9. Ilbey O., Apaydin E., Gursan A., and Cikili N. Bladder leiomyoma: a rare cause of urinary stress incontinence. Arch Ital Urol Androl 72 (2000) 85-87
10. Jacobson G.F., Shaber R.E., Armstrong M.A., and Hung Y.Y. Changes in rates of hysterectomy and uterine conserving procedures for treatment of uterine leiomyoma. Am J Obstet Gynecol 196 (2007) 601.e1-601.e5
11. Catherino W.H., Leppert P.C., Stenmark M.H., Payson M., Potlog-Nahari C., Nieman L.K., et al. Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids. Genes Chromosomes Cancer 40 (2004) 204-217
12. Leppert P.C., Baginski T., Prupas C., Catherino W.H., Pletcher S., and Segars J.H. Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium. Fertil Steril 82 (2004) 1182-1187
13. Leppert P.C., Catherino W.H., and Segars J.H. A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays. Am J Obstet Gynecol 195 (2006) 415-420
14. Arnon H.P., and Wahl M.A. Pharmacology of Curcuma longa. Planta Med 57 (1991) 1-7
15. Sidhu G.S., Singh A.K., Thaloor D., Banaudha K.K., Patnaik G.K., Srimal R.C., et al. Enhancement of wound healing by curcumin in animals. Wound Repair Regen 6 (1998) 167-177
16. Phan T.T., See P., Lee S.T., and Chan S.Y. Protective effects of curcumin against oxidative damage on skin cells in vitro: its implication for wound healing. J Trauma 51 (2001) 927-931
17. Venkatesan N., and Chandrakasan G. Modulation of cyclophosphamide-induced early lung injury by curcumin, an anti-inflammatory antioxidant. Mol Cell Biochem 142 (1995) 79-87
18. Venkatesan N., Punithavathi V., and Chandrakasan G. Curcumin protects bleomycin-induced lung injury in rats. Life Sci 61 (1997) PL51-PL58
19. Venkatesan N. Pulmonary protective effects of curcumin against paraquat toxicity. Life Sci 66 (2000) PL21-PL28
20. Shishodia S., Singh T., and Chaturvedi M.M. Modulation of transcription factors by curcumin. Adv Exp Med Biol 595 (2007) 127-148
21. Aggarwal B.B., Kumar A., and Bharti A.C. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23 363 (2003) 363-398
22. Shishodia S., Amin H.M., Lai R., and Aggarwal B.B. Curcumin (diferuloylmethane) inhibits constitutive NF-κB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 70 (2005) 700-713
23. Malik M, Webb J, Catherino WH. Retinoic acid treatment of human leiomyoma cells transformed the cell phenotype to one strongly resembling myometrial cells. Clin Endocrinol (Oxf). Published online February 1, 2008.
24. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82 (1990) 1107-1112
25. Catherino W.H., and Malik M. Uterine leiomyomas express a molecular pattern that lowers retinoic acid exposure. Fertil Steril 87 (2007) 1388-1398
26. Malik M., and Catherino W.H. Novel method to characterize primary cultures of leiomyoma and myometrium with the use of confirmatory biomarker gene arrays. Fertil Steril 87 (2007) 1168-1172
27. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29 (2001) e45
28. Martel K.M., Ko A.C., Christman G.M., and Stribley J.M. Apoptosis in human uterine leiomyomas. Semin Reprod Med 22 (2004) 91-103
29. Kumar S. Caspase function in programmed cell death. Cell Death Diff 14 (2007) 32-43
30. Johnson C.R., and Jarvis W.D. Caspase-9 regulation: an update. Apoptosis 9 (2004) 423-427
31. Inoue K., Zama T., Kamimoto T., Aoki R., Ikeda Y., Kimura H., et al. TNFα-induced ATF3 expression is bidirectionally regulated by the JNK and ERK pathways in vascular endothelial cells. Genes Cells 9 (2004) 59-70
32. Singh S., and Aggarwal B.B. Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane). J Biol Chem 270 (1995) 24995-25000
33. Jobin C., Bradham C.A., Russo M.P., Juma B., Narula A.S., Brenner D.A., et al. Curcumin blocks cytokine-mediated NF-κB activation and proinflammatory gene expression by inhibiting inhibitory factor I-κB kinase activity. J Immunol 163 (1999) 3474-3483
34. Malik M., Zhao C., Schoene N., Guisti M.M., Moyer M.P., and Magnuson B.A. Anthocyanin-rich extract from Aronia meloncarpa E induces a cell cycle block in colon cancer but not normal colonic cells. Nutr Cancer 46 (2003) 186-196
35. Pan M.H., Chang W.L., Lin-Shiau S.Y., Ho C.T., and Lin J.K. Induction of apoptosis by garcinol and curcumin through cytochrome c release and activation of caspases in human leukemia HL-60 cells. J Agric Food Chem 49 (2001) 1464-1474
36. 2+ and the activation of caspase-3. Anticancer Res 26 (2006) 4379-4389
37. Tan T.W., Tsai H.R., Lu H.F., Lin H.L., Tsou M.F., Lin Y.T., et al. Curcumin-induced cell cycle arrest and apoptosis in human acute promyelocytic leukemia HL-60 cells via MMP changes and caspase-3 activation. Anticancer Res 26 (2006) 4361-4371
38. Bush J.A., Cheung K.J., and Li G. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp Cell Res 271 (2001) 305-314
39. Marín Y.E., Wall B.A., Wang S., Namkoong J., Martino J.J., Suh J., et al. Curcumin downregulates the constitutive activity of NF-κB and induces apoptosis in novel mouse melanoma cells. Melanoma Res 17 (2007) 274-283
40. Dhandapani K.M., Mahesh V.B., and Brann D.W. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFκB transcription factors. J Neurochem 102 (2007) 522-538
41. Cho J.W., Lee K.S., and Kim C.W. Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-α as well as cyclin E in TNF-α-treated HaCaT cells; NF-κB and MAPKs as potential upstream targets. Int J Mol Med 19 (2007) 469-474
42. Woo J.H., Kim Y.H., Choi Y.J., Kim D.G., Lee K.S., Bae J.H., et al. Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis 24 (2003) 1199-1208
43. Jana N.R., Dikshit P., Goswami A., and Nukina N. Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway. J Biol Chem 279 (2004) 11680-11685
44. Lin J.K. Molecular targets of curcumin. Adv Exp Med Biol 595 (2007) 227-243
45. Numsen H Jr. Mitochondrial reactive oxygen species affect sensitivity to curcumin-induced apoptosis. Free Radic Biol Med. Published online January 4, 2008.
46. Liao Y.F., Hung H.C., Hour T.C., Hsu P.C., Kao M.C., Tsay G.J., et al. Curcumin induces apoptosis through an ornithine decarboxylase-dependent pathway in human promyelocytic leukemia HL-60 cells. Life Sci 82 (2008) 367-375
47. Yamamoto H. Interrelation of differentiation, proliferation and apoptosis in cancer cells. J Osaka Dent Univ 29 (1995) 51-60
48. Jiang M.C., Yang-Yen H.F., Yen J.J., and Lin J.K. Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells. Oncogene 13 (1996) 609-616
49. Mehta K., Pantazis P., McQueen T., and Aggarwal B.B. Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs 8 (1997) 470-481
50. Han S.S., Chung S.T., Robertson D.A., Ranjan D., and Bondada S. Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-κB, and p53. Clin Immunol 93 (1999) 152-161
51. Liontas A., and Yeger H. Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma. Anticancer Res 24 (2004) 987-998
52. Lev-Ari S., Starr A., Vexler A., Karaush V., Loew V., Greif J., et al. Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity. Anticancer Res 26 (2006) 4423-4430
53. Yu Z., and Shah D.M. Curcumin down-regulates Ets-1 and Bcl-2 expression in human endometrial carcinoma HEC-1-A cells. Gynecol Oncol 106 (2007) 541-548
54. Lin Y.G., Kunnumakkara A.B., Nair A., Merritt W.M., Han L.Y., Armaiz-Pena G.N., et al. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-κB pathway. Clin Cancer Res 13 (2007) 3423-3430
55. Higashijima T., Kataoka A., Nishida T., and Yakushiji M. Gonadotropin-releasing hormone agonist therapy induces apoptosis in uterine leiomyoma. Eur J Obstet Gynecol Reprod Biol 68 (1996) 169-173
56. Xu Q., Takekida S., Ohara N., Chen W., Sitruk-Ware R., Johansson E.D., et al. Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3 and poly(adenosine 5′-diphosphate-ribose) polymerase expression in cultured human uterine leiomyoma cells. J Clin Endocrinol Metab 90 (2005) 953-961
57. Kwon J.Y., Park K.H., Park Y.N., and Cho N.H. Effect of cetrorelix acetate on apoptosis and apoptosis regulatory factors in cultured uterine leiomyoma cells. Fertil Steril 84 (2005) 1526-1528
58. Chen W., Ohara N., Wang J., Xu Q., Liu J., Morikawa A., et al. A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells. J Clin Endocrinol Metab 91 (2006) 1296-1304
59. Shushan A., Ben-Bassat H., Mishani E., Laufer N., Klein B.Y., and Rojansky N. Inhibition of leiomyoma cell proliferation in vitro by genistein and the protein tyrosine kinase inhibitor TKS050. Fertil Steril 87 (2007) 127-135
60. Salama S.A., Nasr A.B., Dubey R.K., and Al-Hendy A. Estrogen metabolite 2-methoxyestradiol induces apoptosis and inhibits cell proliferation and collagen production in rat and human leiomyoma cells: a potential medicinal treatment for uterine fibroids. J Soc Gynecol Investig 13 (2006) 542-550
61. Liu J., Matsuo H., Xu Q., Chen W., Wang J., and Maruo T. Concentration-dependent effects of a selective estrogen receptor modulator raloxifene on proliferation and apoptosis in human uterine leiomyoma cells cultured in vitro. Hum Reprod 22 (2007) 1253-1259
62. Nam D.H., Ramachandran S., Song D.K., Kwon K.Y., Jeon D.S., Shin S.J., et al. Growth inhibition and apoptosis induced in human leiomyoma cells by treatment with the PPAR gamma ligand ciglitizone. Mol Hum Reprod 13 (2007) 829-836
63. Arici A., and Sozen I. Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertil Steril 73 (2000) 1006-1011
64. Yamada K.M. Cell surface interactions with extracellular materials. Ann Rev Biochem 52 (1983) 761-799
65. Sottile J., and Hocking D.C. Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol Biol Cell 13 (2002) 3546-3559
66. Behera M.A., Feng L., Yonish B., Catherino W., Jung S.H., and Leppert P. Thrombospondin-1 and thrombospondin-2 mRNA and TSP-1 and TSP-2 protein expression in uterine fibroids and correlation to the genes COL1A1 and COL3A1 and to the collagen cross-link hydroxyproline. Reprod Sci 14 (2007) 63-76
67. Gildner C.D., Lerner A.L., and Hocking D.C. Fibronectin matrix polymerization increases tensile strength of model tissue. Am J Physiol Heart Circ Physiol 287 (2004) H46-H53
68. Hocking D.C., Sottile J., and Langenbach K.J. Stimulation of integrin-mediated cell contractility by fibronectin polymerization. J Biol Chem 275 (2000) 10673-10682
69. Rogers R., Norian J., Malik M., Christman G., Abu-Asab M., Chen F., et al. Mechanical homeostasis is altered in uterine leiomyoma. Am J Obstet Gynecol 198 (2008) 474.e1-11
70. Zhang Q., Magnusson M.K., and Mosher D.F. Lysophosphatidic acid and microtubule-destabilizing agents stimulate fibronectin matrix assembly through rho-dependent actin stress fiber formation and cell contraction. Mol Biol Cell 8 (1997) 1415-1425
71. Wu C., Keivens V.M., O'Toole T.E., McDonald J.A., and Ginsberg M.H. Integrin activation and cytoskeletal interaction are essential for the assembly of a fibronectin matrix. Cell 83 (1995) 715-724
72. Roy J., Tran P.K., Religa P., Kazi M., Henderson B., Lundmark K., et al. Fibronectin promotes cell cycle entry in smooth muscle cells in primary culture. Exp Cell Res 273 (2002) 169-177
73. Chen S., Khan Z.A., Cukiernik M., and Chakrabarti S. Differential activation of NF-κB and AP-1 in increased fibronectin aynthesis in target organs of diabetic complications. Am J Physiol Endocrinol Metab 284 (2003) E1089-E1097
74. Payson M, Malik M, Morris SSN, Segars JH, Chason R, Catherino WH. Activating transcription factor 3 gene expression in uterine leiomyoma: a molecular link between tissue stress and leiomyoma development. Fertil Steril, submitted.